Tech Company Financing Transactions

Principia Biopharma Funding Round

On 12/31/2014, Principia Biopharma announced $25.3 million in funding from Morgenthaler Ventures, Sofinnova Ventures and private investors.

Transaction Overview

Company Information

Company Status

Acquired or Merged

Industry

Biopharmaceutical

Mailing Address

400 East Jamie Ct. 302
South San Francisco, CA 94080
USA

Phone

(650) 416-7700

Website

www.principiabio.com

Email Address

[email protected]

Overview

Principia is committed to changing the drug development paradigm. The company's reversible covalent technology platform rapidly and reliably produces compounds with superior selectivity, enabling development of multiple product candidates with substantial commercial potential.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Martin Babler

        

Chief Financial Officer

Christopher Chai

        

Chief Medical Officer

Steve Gourlay

        

Chief Scientific Officer

Jens Funk

        

Vice President

Ken Brameld

        

VP - Bus. Development

Roy Hardiman

        

VP - Human Resources

Betsy Santos

        

VP - Operations

Ann Neale

        

VP - Operations

Stefani Wolff

        

Browse more venture capital transactions:

Prev: 12/31/2014: Cantex Pharmaceuticals venture capital transaction
Next: 12/31/2014: Needle venture capital transaction

Share this article

About Our Venture Capital Transactions Database

We do our best to report on all VC transactions involving tech companies. All VC database entries reported here are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary